Hemostatic Complications of Bone Marrow Transplantation
คำสำคัญ:
-บทคัดย่อ
-
Downloads
เอกสารอ้างอิง
Nevo S, Swan V, Enger C, et al. Acute bleeding after bone marrow transplantation (BMT) - Incidence and effect on survival. A quantitative analysis in 1,402 patients. Blood 1998;91:1469-77.
Kroll MH, McCarthy PL, Jr. Hemostatic complications of bone marrow transplantation. In : Loscalzo J, Schafer AI,eds. Thrombosis and Hemornorrhage. Boston : Blackwell Scientific Publications, 1994:1039-50.
Beutler E. Platelet transtusions: the 20,000/ trigger. Blood 1993;81:1411-3.
Kaur S, Cooper G, Fakult S, Lazarus HM. Incidence and outcome of overt gastrointestinal bleeding in patients undergoing bone marrow transplantation. Dig Dis Sci 1996;41:598-603.
Shuhart MC, McDonald GB. Gastrointestinal and hepatic complications. In : Forman SJ, Blume KG, Thomas ED, eds. Bone Marrow Transplant. Cambridge : MA Blackwell Scientific, 1994;454-81.
Vishny ML, Blades EW, Creger RJ, et al. Role of upper endoscopy in evaluation of upper gastrointestinal symptoms in patients undergoing bone marrow transplantation. Cancer Invest 1994;12:384-9.
Marmaduke DP, Greenson JK, Cunningham I, et al. Gastric vascular ectasia in patients undergoing bone marrow transplantation. Am J Clin Pathol 1994;102:194-8.
First LR, Smith BR, Lipton J, et al. Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes. Blood 1985;65:368-74.
Letendre L, Hoagland HC, Gertz MA. Hemorrhagic cystitis complicating bone marrow transplantation. Mayo Clin Proc 1992;67:128-30.
Brugieres L, Hartmann O, Travagli JP, et al. Hemorrhagic cystitis following high-dose chemotherapy and bone marrow transplantation in children with malignancies: Incidence, clinical course, and outcome. J Clin Oncol 1989;7:194-9.
Sencer SF, Haake RJ, Weisdoft DJ. Hemorrhagic cystitis after bone marrow transplantation. Transplantation 1993;56:875-9.
Russell SJ, Vowels MR Vale T. Hemorrhagic cystitis in paediatric bone marrow transplant patients: An association with infective agents, GVHD and prior cyclophosphamide. Bone Marrow Transplant 1994;13:533-9.
Yang CC, Hurt DD, Case LD, Asstmos DG. Hemorrhagic cystitis in bone marrow transplantation. Urology 1994;44:322-8.
Thomas AE, Patterson J, Prentice HG, et al. Hemorrhagic cystitis in bone marrow transplantation patients: Possible increased risk associated with prior busulfan therapy. Bone Marrow Transplant 1987;1:347-55.
Atkinson K, Biggs JC, Golovsky D, et al. Bladder irrigation does not prevent hemorrhagic cystitis in bone marrow transplant recipients. Bone Marrow Transplant 1991;7:351-4.
de Vries CR, Freiha FS. Hemorrhagic cystiris: A review. J Urol 1990;143:1-9.
Robbins RA, Linder J, Stahl MG, et al. Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. Am J Med 1989;87:511-8.
Metcalf JP, Rennard SI, Reed EC, et al. Corticosteroids as adjunctive therapy for diffuse alveolar hemorrhage associated with bone marrow transplantation. Am J Med 1994;96:327-34.
Chao NJ, Duncan SR, Long GD, et al. Corticosteroid therapy for diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. Ann Intern Med 1991;114:145-6.
Mulder PO, Meinesz AF, de Vries EG, Mulder NH. Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. Am J Med 1991;90:278.
Seiden MV, Elias A, Ayash L, et al. Pulmonary toxicity associated with high dose chemotherapy in the treatment of solid tumors with autologous marrow transplant: An analysis of four chemotherapy regimens. Bone Marrow Transplant 1992;10:57-63.
Schmidt-Wolf I, Schwerdffeger R, Schwella N, et al. Diffuse pulmonary alveolar hemorrhage after allogeneic bone marrow transplantation. Ann Hematol 1993;67:139-41.
Srivastava A, Gottlieb D, Bradstook KF. Diffuse alveolar haemorthage associated with microangiopathy after allogeneic bone marrow transplantation. Bone Marrow Transplant 1995;15:863-7.
Bearman SI. The syndrome of hepatic vencocclusive disease after marrow transplantation. Blood 1995;85:3005-20.
Bras G, Jelliffe DB, Stuart KL. Venoocclusive disease of the liver with nonportal type of cirrhosis, occuring in Jamaica. Arch Pathol 1954;57:285.
Mohabbat O, Srivastava RN, Younos MS, et al. An outbreak of hepatic venoocclusive disease in North-Western Afghanistan. Lancet 1976;2:269-70.
Ridker PM, McDermott WV. Comfrey tea and hepatic venoocclusive disease. Lancet 1989;1:657-8.
Tandon BN, Tandon RK, Tandon HD, et al. An epidemic of venoocclusive disease of liver in central India. Lancet 1976;2:271-2.
Faioni EM, Mannucci PM. Venoocclusive disease of the liver after bone marrow transplantation: The role of hemostasis Leukemia Lymphoma 1997;25:233-45.
Frickhofen N, Wiesneth M. Jainta C, et al. Hepatis C virus infection is a risk factor for liver failure from venoocclusive disease after bone marrow transplantation. Blood 1994;83:1998-2004.
Shulman H., McDonald G, Mathews D, et al. An analysis of hepatic venoocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation. Gastroenterol 1980;79:1178-91.
McDonald G, Sharma P, Mathews D, et al. Venocclusive disease of the liver after bone marrow transplantation. Diagnosis, incidence and predisposing factors. Hepatology 1984;4:116-22.
Shulman. H M, Fisher LB, Schoch HG, et al. Venoocclusive disease of the liver after marrow transplantation: Histological correlates of clinical signs and symptoms. Hepatology 1994;19:1171-80.
Shulman HM, Gown AM, Nugent DI. Hepatic venoocclusive disease after bone marrow transplantation. Immunohistochemicai identification of the material within occluded central venules. Am J Pathol 1987;127:549-58.
Holler E, Kolb H, Miller A, et al. Increased serum levels of tumor necrosis factor-Ct precede major complications of bone marrow transplantation. Blood 1990:75:1011-6.
Remberger M, Ringden O. Increased levels of soluble interleukin-2 receptor in venoocclusive disease of the liver after allogenic bone marrow transplantation. Transplantation 1995;60:1293-9.
McDonald GB, Hinds MS, Fisher LD, et al. Venoocclusive disease of the liver and mutiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993;118:255-67.
Jones RJ, Lee KSK, Beschorner WE, et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 1987;44:778-83.
Bearman SI, Anderson GL, Mori M, et al. Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. J Clin Oncol 1993;11:1729-36.
Ozkaynak M, Weinberg K, Kohn D, et al. Hepatic venoocclusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors and clinical outcome. Bone Marrow Transplant 1991;7:467-74.
Carreras E, Granena A, Rozman C. Hepatic venoocclusive disease after bone marrow transplantation. Blood Reviews 1993;7:43-51.
Grochow LB, Jones RJ, Brundrett RB, et al. Pharmacokinetics of busulfan: Correlation with venocclusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol 1989;25:55.
Hassan M, Oberg G, Bekassy AN, et al. Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology. Cancer Chemother Pharmacol 1991;28:130-4.
Yeager AM, Wagner JE, Graham ML, et al. Optimization of busulfan dosage in children undergoing bone marrow transplantation: A pharmacokinetic study of dose escalation. Blood 1992;80:2425-8.
Grochow LB. Busulfan disposition: The role of therapeutic monitoring in bone marrow transplantation induction regimens. Semin Oncol 1993,20:18-29-29.
Ljungman P, H gglund H, L nnqvist B, et al. Hepatitis C virus as a risk factor for the development of venoocclusive disease of the liver. Blood 1994;84:1349-50.
Mouelhi M, Kauffman FC. Sublobular distribution of transferases and hydrolases associated with glucuronide, sulfate and glutathione conjugation in human liver. Hepatology 1986;6:450-6.
DeLeve LD. Dacarbazine toxicity in murine liver cells: A model of hepatic endothelial injury and glutathione defense. J Pharm Exp Ther 1994;286.1261-70.
Teicher BA, Crawford JM, Holden SA, et al. Glutathione monoethyl ester can selective protect liver from high dose BCNU or cyclophosphamide. Cancer 1988;62:1275-81.
Shulman HM, Luk K, Deeg HJ, et al. Induction of hepatic venoocclusive disease in dogs. Am J Pathol 1987;126:114-25.
Shulman HM, McDonald GB, Matthews D, et al. An analysis of hepatic venoocclusive disease and centrilobular hepatic degenerating following bone marrow transplantation. Gastroenterol 1980;79:1178-91.
Ganem G, Saint-Marc Girardin M-F, Kuentz M, et al. Venoocclusive disease of the liver after allogeneic bone marrow transplantation in man. Int J Rad Oncol Biol Phys 1988;14:879-84.
Rappaport AM, Knoblauch M, Zelin S, et al. Experimental hepatic venoocclusive disease. In vivo micro-circulatory study. Adv Microcirc 1969;2:69.
Andus T, Bauer J, Gerok W. Effects of cytokines on the liver. Hepatology 1991;13,364-75.
Scoazec JY, Feldmann G. In situ immunophenotyping study of endothelial cells of the human hepatic sinusoid: results and functional implications. Hepatology 1991;14:789-97.
Edgington TS, Nackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost 1991;66:67-79.
Shulman HM, Gooley T, Dudley MD, et al. Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant. recipients. Transplantation 1995,59:1015-22.
Carreras E, Granena A, Navasa M, et al. On the reliability of cinical criteria for the diagnosis of hepatic venoocclusive disease. Ann Hematol 1993;66:77-80.
Nicolau C, Bru C, Carreras E, et al. Sonographic diagnosis and hemodynamic correlation in in venoocclusive disease of the liver. J Ultrasound Med 1993;12:437-40.
Zieger MM, Koscielniak E. Diagnosis and follow-up of venoocclusive disease of the liver by use of Doppler ultrasound :A case report. Pediatr Radiol 1993;23:137-9.
Deeg KH, Glockel U, Richter R, Beck J. Diagnosis of venoocclusive disease of the liver by color-coded Doppler sonography. Pediatr Radiol 1993;23:134-6.
Teefey SA, Brink JA, Borson RA, Middleton WD. Diagnosis of venoocclusive disease of the liver after bone marrow transplantation: value of duplex sonography. Am J Roentgenol 1995;164:1397-401.
Jacobson AF, Teefey SA, Higano CA, Bianco JA. Increased lung uptake of "Tcm-sulphur colloid as an early indicator of the development of hepatic venoocclusive disease in bone marrow transplant patients. Nuclear Med Communications 1993;14:706-11.
Collins PW, Gutteridge CN, O'Driscoll A, et al. von Willebrand factor as a marker of endothelial cell activation following BMT. Bone Marrow Transplantation 1992;10:499-506.
ดาวน์โหลด
เผยแพร่แล้ว
ฉบับ
ประเภทบทความ
สัญญาอนุญาต
อนุญาตภายใต้เงื่อนไข Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
